Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Operating Expenses | 2,714 | 44 | 60 | 30 | 49 |
| Operating Income | -2,284 | -44 | -60 | -30 | -49 |
| Other Income | -9 | 1 | 1 | 3 | 3 |
| Pre-tax Income | -2,293 | -43 | -59 | -27 | -46 |
| Net Income Continuous | -2,293 | -43 | -59 | -27 | -46 |
| Net Income | $-2,293 | $-43 | $-59 | $-27 | $-46 |
| EPS Basic Total Ops | 2.70 | -1.00 | -2.00 | -1.00 | -2.00 |
| EPS Basic Continuous Ops | 3.11 | -1.49 | -2.01 | -0.92 | -1.58 |
| EPS Diluted Total Ops | 2.70 | -1.00 | -2.00 | -1.00 | -2.00 |
| EPS Diluted Continuous Ops | 3.11 | -1.49 | -2.01 | -0.92 | -1.58 |
| EBITDA(a) | $-2,714 | $-44 | $-60 | $-30 | $-49 |